Cart summary

You have no items in your shopping cart.

Icaritin

SKU: orb1222830

Description

Icaritin is an oral traditional Chinese medicine, derived from barrenwort, which targets the estrogen receptor α36. IC50 values for Icaritin are 8,13 and 18 μM for K562, CML-CP and CML-BC cells respectively. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling. Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells.

Images & Validation

Key Properties

CAS Number118525-40-9
MW368.38
Purity>98% (HPLC)
FormulaC21H20O6
SMILESCC(=CCc1c(cc(c2c1oc(c(c2=O)O)c1ccc(cc1)OC)O)O)C
TargetJAK2| STAT3
SolubilityDMSO : 14 mg/mL 38.00 mM;

Bioactivity

In Vivo
Animal model: Female NOD-SCID nude mice (6-8 weeks old) with K562 cells. Dosage: 4 mg/kg and 8 mg/kg. Administration: Intraperitoneal injection; daily; for 10 weeks. Result: Could prolong lifespan of NOD-SCID nude mice inoculated with K562 cells without suppression of bone marrow.
In Vitro
Cell Proliferation Assay Cell line: K562, imatinib-resistant cells and primary CML cells. Concentration: 4 μM, 8 μM, 16 μM, 32 μM and 64 μM. Incubation time: 48 hours. Result: Inhibited cell proliferation. Apoptosis Analysis Cell line: K562 or primary cells. Concentration: 0 μM, 4 μM, 8 μM, 16 μM, 32 μM and 64 μM. Incubation time: 48 hours. Result: Induced K562 or primary cells apoptosis. Cell Cycle Analysis Cell line: K562 cells. Concentration: 32 μM. Incubation time: Result: Cell population in the sub-G1 phase was increased. Western blot analysis. Cell line: K562 cells. Concentration: 0 μM, 4 μM, 8 μM, 16 μM, 32 μM and 64 μM. Incubation time: 48 hours. Result: Inhibited MAPK/ERK/JNK downstream signaling and diminishes Jak2/Stat3/Akt expression.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Icaritin

Similar Products

  • Icaritin-3-O-rhamnoside [orb2663482]

    108195-76-2

    532.54

    C27H32O11

    50 mg, 10 mg
  • Icaritin [orb1304239]

    98.98%

    118525-40-9

    368.38

    C21H20O6

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 mg, 1 ml x 10 mM (in DMSO)
  • Antitumor agent-92 [orb1982638]

    2922842-01-9

    611.68

    C33H41NO10

    5 mg, 50 mg
  • Icaritin (Standard) [orb3140507]

    118525-40-9

    368.38

    C21H20O6

    10 mg
  • SNG-1153 [orb1226261]

    >98% (HPLC)

    1446712-19-1

    406.3519

    C21H17F3O5

    1 g, 500 mg, 200 mg, 5 mg, 25 mg, 10 mg, 100 mg, 2 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Icaritin (orb1222830)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 110.00
10 mg
$ 180.00
25 mg
$ 280.00
50 mg
$ 410.00
100 mg
$ 590.00